| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J Slánský, O Kadlec, J Sevcík, K Mase. Further evidence on the interaction of muramyl dipeptide with the serotonergic system. International journal of immunopharmacology. vol 18. issue 1. 1997-01-28. PMID:8732429. |
the interaction of mdp with the serotonergic system thus involved not only potentiation of the postsynaptic effect of higher 5-ht concentrations, which might have been mediated via the 5-ht1 subsystem, but also presynaptic inhibition. |
1997-01-28 |
2023-08-12 |
Not clear |
| E F Colecchia, P D Penev, P C Zee, F W Ture. Phase-shifting effects of a serotonin agonist in tau mutant hamsters. Brain research. vol 730. issue 1-2. 1997-01-28. PMID:8883908. |
since, recent evidence suggests that serotonergic pathways may play an important role for the non-photic phase resetting of the rodent circadian pacemaker, prcs to the serotonin (5-ht) agonist, 8-oh-dpat (5 mg/kg i.p), were generated in both wild-type and tau mutant hamsters kept in constant darkness. |
1997-01-28 |
2023-08-12 |
Not clear |
| N A Darmani, S L Reeve. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice. Pharmacology, biochemistry, and behavior. vol 55. issue 1. 1997-01-23. PMID:8870031. |
this effect should enhance the synaptic concentration of 5-ht (5-hydroxytryptamine) in serotonergic terminal fields, which may then activate postsynaptic 5-ht receptors. |
1997-01-23 |
2023-08-12 |
mouse |
| N A Darmani, S L Reeve. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice. Pharmacology, biochemistry, and behavior. vol 55. issue 1. 1997-01-23. PMID:8870031. |
these results suggest that an endogenous 5-ht tone via the discussed mechanism controls the terminal field synapticactivity of serotonergic neurons in mice. |
1997-01-23 |
2023-08-12 |
mouse |
| Y Henry, B Sève, A Mounier, P Ganie. Growth performance and brain neurotransmitters in pigs as affected by tryptophan, protein, and sex. Journal of animal science. vol 74. issue 11. 1997-01-23. PMID:8923184. |
the greater sensitivity of feed intake and growth of pigs, especially females, to trp deficiency in the presence of additional cp may have been related to a more critical serotonergic activity, when hypothalamic serotonin concentration fell below a threshold level. |
1997-01-23 |
2023-08-12 |
Not clear |
| Q Li, I Murakami, S Stall, A D Levy, M S Brownfield, D E Nichols, L D Van de Ka. Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA). The Journal of pharmacology and experimental therapeutics. vol 279. issue 3. 1997-01-23. PMID:8968349. |
serotonin (5-hydroxytryptamine, 5-ht)-releasing drugs are important experimental tools to examine the role of serotonergic nerve terminals in the secretion of hormones. |
1997-01-23 |
2023-08-12 |
rat |
| F Biver, F Lotstra, M Monclus, D Wikler, P Damhaut, J Mendlewicz, S Goldma. Sex difference in 5HT2 receptor in the living human brain. Neuroscience letters. vol 204. issue 1-2. 1997-01-17. PMID:8929969. |
distinct liability for men and women to suffer from some psychiatric disorders responding to serotonergic agents may be related to differences in brain serotonin receptors. |
1997-01-17 |
2023-08-12 |
human |
| D F Papolos, Y M Yu, E Rosenbaum, H M Lachma. Modulation of learned helplessness by 5-hydroxytryptamine2A receptor antisense oligodeoxynucleotides. Psychiatry research. vol 63. issue 2-3. 1997-01-16. PMID:8878316. |
these data support the view that central 5ht, mediated by the 5ht2a receptor, participates in regulating behaviors that are affected by inescapable stress, and that the induction of behavioral depression may be specifically regulated via serotonergic pathways that terminate in this hippocampal subfield. |
1997-01-16 |
2023-08-12 |
rat |
| M R Pranzatelli, E Tate, I Galvan, A Wheele. A controlled trial of 5-hydroxy-L-tryptophan for ataxia in progressive myoclonus epilepsy. Clinical neurology and neurosurgery. vol 98. issue 2. 1997-01-15. PMID:8836591. |
serotonergic drugs that work through mechanisms different than l-5-htp may be more effective in correcting the abnormal serotonergic neurotransmission suggested by reduction of serotonin metabolites in cerebrospinal fluid in patients with progressive myoclonus epilepsy. |
1997-01-15 |
2023-08-12 |
human |
| H C Dringenberg, C H Vanderwol. 5-Hydroxytryptamine (5-HT) agonists: effects on neocortical slow wave activity after combined muscarinic and serotonergic blockade. Brain research. vol 728. issue 2. 1997-01-15. PMID:8864480. |
5-hydroxytryptamine (5-ht) agonists: effects on neocortical slow wave activity after combined muscarinic and serotonergic blockade. |
1997-01-15 |
2023-08-12 |
rat |
| H C Dringenberg, C H Vanderwol. 5-Hydroxytryptamine (5-HT) agonists: effects on neocortical slow wave activity after combined muscarinic and serotonergic blockade. Brain research. vol 728. issue 2. 1997-01-15. PMID:8864480. |
even though agonists at 5-ht receptors can produce some activation of neocortical slow wave activity after combined cholinergic and serotonergic blockade, this effect is not equivalent to that observed after restoration of endogenous 5-ht transmission. |
1997-01-15 |
2023-08-12 |
rat |
| H Saito, M Matsumoto, H Togashi, M Yoshiok. Functional interaction between serotonin and other neuronal systems: focus on in vivo microdialysis studies. Japanese journal of pharmacology. vol 70. issue 3. 1997-01-15. PMID:8935715. |
5-ht release is negatively regulated not only by somatodendritic 5-ht1a and terminal 5-ht1b (5-ht1d) autoreceptors but also by alpha 2-adrenergic and mu-opioid heteroreceptors that are located on serotonergic nerve terminals. |
1997-01-15 |
2023-08-12 |
rat |
| G E Ruof. Depression in the patient with chronic pain. The Journal of family practice. vol 43. issue 6 Suppl. 1997-01-15. PMID:8969710. |
regardless of their etiology, evidence exists to suggest that depression and chronic pain share common biologic pathways, namely, the serotonergic (5-ht) and noradrenergic systems. |
1997-01-15 |
2023-08-12 |
Not clear |
| R T Miller, S S Lau, T J Monk. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats. Chemical research in toxicology. vol 9. issue 2. 1997-01-14. PMID:8839050. |
however, although 5-(glutathion-s-yl)-alpha-meda reproduced some of the effects of mda on the dopaminergic system and was capable of causing acute increases in 5-ht turnover, a single icv injection of 5-(glutathion-s-yl)-alpha-meda did not result in long-term serotonergic toxicity. |
1997-01-14 |
2023-08-12 |
rat |
| T de Boe. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. International clinical psychopharmacology. vol 10 Suppl 4. 1997-01-08. PMID:8930006. |
it increases serotonergic cell-firing in the dorsal raphe and 5-ht release in the hippocampus as measured by microdialysis. |
1997-01-08 |
2023-08-12 |
Not clear |
| A Suwalska, J Rybakowsk. [Biological mechanisms of drug-resistant depression]. Psychiatria polska. vol 30. issue 5. 1997-01-08. PMID:8984513. |
efficacy of therapeutic strategies enhancing serotonergic function such as potentiation of tricyclic antidepressants with lithium or fluoxetine as well as effectiveness of selective serotonin reuptake inhibitors in drug-resistant depression may support this hypothesis. |
1997-01-08 |
2023-08-12 |
Not clear |
| M G von Halling Laier, L F Gra. [Serotonin syndrome and malignant neuroleptic syndrome. A review based on the material from the National Board of Adverse Drug Reactions]. Ugeskrift for laeger. vol 158. issue 48. 1997-01-07. PMID:8984761. |
the report describes four cases of serotonergic hyperstimulation classified as serotonin syndrome (ss) and 13 cases of supposed neuroleptic malignant syndrome (nms), all reported to the national board of adverse drug reactions. |
1997-01-07 |
2023-08-12 |
Not clear |
| A Linden, D Desmecht, S Vandenput, M L Van de Weerdt, P Lekeu. Effect of serotonergic blockade on calf pulmonary function after the intravenous administration of 3-methylindole. Journal of comparative pathology. vol 114. issue 4. 1997-01-06. PMID:8814531. |
because the effect was abolished by pretreatment with antiserotonin drugs, it is suggested that 3-mi acts either directly by stimulating serotonergic receptors or indirectly through the release of serotonin from platelets. |
1997-01-06 |
2023-08-12 |
Not clear |
| H Cransac, J M Cottet-Emard, J M Pequignot, L Peyri. Monoamines (noradrenaline, dopamine, serotonin) in the rat cochlear nuclei: endogenous levels and turnover. Hearing research. vol 90. issue 1-2. 1996-12-30. PMID:8975006. |
noradrenaline (na), dopamine (da), serotonin (5-ht) and their metabolites, 3-methoxy,4-hydroxyphenylglycol (mhpg) and 5-hydroxyindoleacetic acid (5-hiaa), were determined using high-performance liquid chromatography with electrochemical detection in the rat anteroventral cochlear nucleus (avcn), in the dorsal part of the nucleus including the dorsal cochlear nucleus (dcn) and the posteroventral cochlear nucleus (pvcn) and as a comparison, in the locus coeruleus (lc) and dorsal raphe nucleus (rd) which contain the corresponding noradrenergic and serotonergic cell bodies. |
1996-12-30 |
2023-08-12 |
rat |
| R Sandy. Treatment with weak electromagnetic fields attenuates carbohydrate craving in a patients with multiple sclerosis. The International journal of neuroscience. vol 86. issue 1-2. 1996-12-26. PMID:8828061. |
pharmacological studies have implicated serotonergic (5-ht) neurons in the regulation of food intake and food preference. |
1996-12-26 |
2023-08-12 |
Not clear |